Has Sarah Hartzell, PA received payments from drug or device companies?

Yes. Drug and device makers reported $559 in general payments to Sarah Hartzell, PA across 34 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Sarah Hartzell, PA did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Sarah Hartzell, PA come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Sarah Hartzell, PA

Physician Assistant · Post Falls, IDNPI 1407049356

Payments from drug & device makers

$559in general payments, 2019–2025

Across 34 payments — averaging $16.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Novo Nordisk$113
AbbVie$98
Johnson & Johnson$60
Novartis$48
Sanofi-aventis U.S. LLC$42
Amgen$31
plus $166 from 9 others

What the payments were for

Food & beverage$559100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Novo Nordisk	6	$113
AbbVie	6	$98
Johnson & Johnson	4	$60
Novartis	2	$48
Sanofi-aventis U.S. LLC	3	$42
Amgen(2 entities)	2	$31
AstraZeneca	2	$27
Biohaven Pharmaceuticals, Inc.	2	$27
Almatica Pharma LLC	1	$22
Takeda Pharmaceuticals U.S.A., Inc.	1	$19
Eisai Inc.	1	$16
Therapeuticsmd, Inc.	1	$16
Lilly USA, LLC	1	$15
Boston Scientific	1	$13
GSK	1	$12

How this compares

$559 in reported general payments places this provider in the 60th percentile of 1,027 physician assistant providers in Idaho.

See all physician assistant providers in Idaho →

Medicare billing

Part B allowed, 2024

$27,310

Medicare patients

267

Services billed

397

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst	32	$507
Albuterol Sulfate HfaAlbuterol Sulfate	22	$462
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav	30	$273
Cephalexin	27	$208
Azithromycin	34	$157
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim	17	$107
Doxycycline Hyclate	12	$90
Prednisone	25	$49
Amoxicillin	14	$47

Paid to pharmacies, not to this prescriber.

Payments from drug & device makers

Who reported the general payments

How this compares

Medicare billing

Most prescribed under Part D

Other physician assistant in Post Falls